Editorial Comment to "The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion".
Takeo KosakaNozomi HayakawaPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)